CVS HEALTH Corp
Government Contracts & Awards
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
CVS Health Update: The C- Student Now Pulling Down A B+
CVS Health turnaround update: improving margins, cash flow and EPS outlookâbut valuation looks richer. Read the latest analysis on the stock and the upcoming Q2 earnings print here.
What A Patient Holder Is Really Paying For CVS Health Stock
The sticker price on CVS shares looks high, but the real question is what it costs on the earnings expected two years from now.
CVS Health (CVS) Opens Its First Neighborhood Pharmacy In Houston
CVS Health opened its first new pharmacy focused CVS Pharmacy in Houston, introducing a neighborhood format aimed at expanding access to pharmacy care. The company plans to roll out nearly 20 similar locations across the U.S., including additional sites in the Houston area. This move is part of CVS Health's effort to realign its retail footprint and respond to changing consumer preferences for in person pharmacy services. For investors tracking NYSE:CVS, the launch of this new format comes...
CVS Health CEO David Joyner warns private insurers won't cover GLP-1s for weight loss until drug prices drop
Insurance carriers need more proof that paying today’s GLP-1 drug prices will create “enough downstream savings,” assuming that people are healthier long term.
CVS Pharmacy® celebrates opening of first pharmacy-focused location in Houston
CVS Health® (NYSE: CVS) today unveiled its first pharmacy-focused CVS Pharmacy® in Houston. The new pharmacy, located at 8503A Gulf Freeway in south Houston, will help bridge gaps in pharmacy care and make it easier for community members to access medications, immunizations and other health care services provided by pharmacists.
CVS Health (CVS) Stock Looks Pricey On FTC Insulin Settlement
CVS Health stock has climbed sharply over the past year, yet its valuation checks lean expensive. This puts the recent share price strength under closer scrutiny for anyone considering the current upside from here. Over the last 1 year, CVS Health has returned 74.4%, a strong run that raises the bar for what future performance needs to justify at today’s price. Regulatory settlements around pharmacy benefit management and past compliance issues can remove some overhang but also highlight...
How Investors May Respond To CVS (CVS) Dividend Move And GLP‑1 Strategy Across Its Health Platform
Earlier this month, CVS Health’s board approved a quarterly dividend of US$0.665 per share, payable on August 3, 2026, to shareholders of record as of July 23, 2026, while Aetna leadership highlighted the clinical importance of GLP‑1 weight-loss drugs for diabetes and obesity care. Together with improving provider‑payer trust at Aetna and upbeat analyst research, management’s focus on GLP‑1 access and support has reinforced perceptions of CVS Health’s evolving role across insurance,...
Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”
Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite. RBC raised its price target on CVS Health, and Cramer connected that call to a ... Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”
What CVS Health Stock Was Telling You About Its Three-Dollar Earnings Prize
Before the stock surged, management laid out a turnaround plan for its Aetna unit that was so explicit, they practically put a price tag on it.
CVS Health: The Surprising Healthcare Outlier
CVS Health delivered a Q1 beat-and-raise, expects margin expansion in 2026, and projects low double-digit investor returns. Read more on CVS stock here.
Congressional Trades in $CVS
Insider Trades (Form 4)
AGUIRRE FERNANDO
Key People
AGUIRRE FERNANDO
Director
Political Giving
$284,055 given to 55 candidates across 124 disclosed contributions (FEC Schedule A).
Katherine M. Clark
Bradley S. Schneider
Guy Mr Reschenthaler
Kevin Hern
Seth Magaziner
Blake Moore
Terri A. Sewell
Gus M. Bilirakis
Darin McKay LaHood
John B. Larson
Adrian Smith
Suzan K. DelBene
Ashley Moody
Ann Wagner
Linda T. Sanchez
Jamie Raskin
Jennifer McClellan
Frank Pallone
Hakeem S. Jeffries
Susie Lee
+ 35 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro